Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Daiana Stolz:

Search results

Items: 1 to 20 of 157

1.

Continuous professional development: elevating thoracic oncology education in Europe.

van Geffen WH, Blum TG, Aliberti S, Blyth KG, Bostantzoglou C, Farr A, Grigoriu B, Hardavella G, Huber RM, Maskell N, Massard G, Rahman NM, Stolz D, van Meerbeeck J.

Breathe (Sheff). 2019 Dec;15(4):279-285. doi: 10.1183/20734735.0296-2019.

2.

Meeting challenges in delivery of patient care: a reflection on the involvement of ERS in CPD of respiratory physicians.

Mitchell S, Sehlbach C, Driessen E, Farr A, Grant J, Konge L, Pannetier C, Schut S, Stolz D, Rohde G.

Breathe (Sheff). 2019 Sep;15(3):e97-e103. doi: 10.1183/20734735.0172-2019.

3.

Pharmacological treatment and current controversies in COPD.

Cazzola M, Rogliani P, Stolz D, Matera MG.

F1000Res. 2019 Aug 29;8. pii: F1000 Faculty Rev-1533. doi: 10.12688/f1000research.19811.1. eCollection 2019. Review.

4.

The ERS fellowship portfolio: fostering excellence and diversity.

Morty RE, Donnelly LE, Stolz D, Roche N, Welte T, Forrest KA, Brightling CE, Brusselle GG.

Eur Respir J. 2019 Sep 5;54(3). pii: 1901503. doi: 10.1183/13993003.01503-2019. Print 2019 Sep. No abstract available.

PMID:
31488590
5.

Bronchial thermoplasty decreases airway remodelling by blocking epithelium-derived heat shock protein-60 secretion and protein arginine methyltransferase-1 in fibroblasts.

Sun Q, Fang L, Roth M, Tang X, Papakonstantinou E, Zhai W, Louis R, Heinen V, Schleich FN, Lu S, Savic S, Tamm M, Stolz D.

Eur Respir J. 2019 Dec 4;54(6). pii: 1900300. doi: 10.1183/13993003.00300-2019. Print 2019 Dec.

PMID:
31467116
6.

Time-course of upper respiratory tract viral infection and COPD exacerbation.

Stolz D, Papakonstantinou E, Grize L, Schilter D, Strobel W, Louis R, Schindler C, Hirsch HH, Tamm M.

Eur Respir J. 2019 Oct 10;54(4). pii: 1900407. doi: 10.1183/13993003.00407-2019. Print 2019 Oct.

PMID:
31391222
7.

Biomarkers and clinical scoring systems in community-acquired pneumonia.

Karakioulaki M, Stolz D.

Ann Thorac Med. 2019 Jul-Sep;14(3):165-172. doi: 10.4103/atm.ATM_305_18. Review.

8.

Guiding antibiotic treatment with inflammatory biomarkers in COPD? Another brick in the wall.

Schuetz P, Stolz D.

Eur Respir J. 2019 May 23;53(5). pii: 1900562. doi: 10.1183/13993003.00562-2019. Print 2019 May. No abstract available.

PMID:
31123023
9.

Benralizumab for the Prevention of COPD Exacerbations.

Criner GJ, Celli BR, Brightling CE, Agusti A, Papi A, Singh D, Sin DD, Vogelmeier CF, Sciurba FC, Bafadhel M, Backer V, Kato M, Ramírez-Venegas A, Wei YF, Bjermer L, Shih VH, Jison M, O'Quinn S, Makulova N, Newbold P, Goldman M, Martin UJ; GALATHEA Study Investigators; TERRANOVA Study Investigators.

N Engl J Med. 2019 Sep 12;381(11):1023-1034. doi: 10.1056/NEJMoa1905248. Epub 2019 May 20.

PMID:
31112385
10.

Differences in COPD Exacerbation Risk Between Women and Men: Analysis From the UK Clinical Practice Research Datalink Data.

Stolz D, Kostikas K, Loefroth E, Fogel R, Gutzwiller FS, Conti V, Cao H, Clemens A.

Chest. 2019 Oct;156(4):674-684. doi: 10.1016/j.chest.2019.04.107. Epub 2019 May 16.

PMID:
31103696
11.

Towards eradication of chronic obstructive pulmonary disease: a Lancet Commission.

Dransfield M, Stolz D, Kleinert S; Lancet COPD Commissioners.

Lancet. 2019 May 4;393(10183):1786-1788. doi: 10.1016/S0140-6736(19)30950-X. No abstract available. Erratum in: Lancet. 2019 May 18;393(10185):2038.

PMID:
31057152
12.

Does trumpet playing affect lung function?-A case-control study.

Studer L, Schumann DM, Stalder-Siebeneichler A, Tamm M, Stolz D.

PLoS One. 2019 May 2;14(5):e0215781. doi: 10.1371/journal.pone.0215781. eCollection 2019.

13.

Stability of the Blood Eosinophilic Phenotype in Stable and Exacerbated COPD.

Schumann DM, Tamm M, Kostikas K, Stolz D.

Chest. 2019 Sep;156(3):456-465. doi: 10.1016/j.chest.2019.04.012. Epub 2019 Apr 29.

PMID:
31047957
14.

Biomarkers in Pneumonia-Beyond Procalcitonin.

Karakioulaki M, Stolz D.

Int J Mol Sci. 2019 Apr 24;20(8). pii: E2004. doi: 10.3390/ijms20082004. Review.

15.

A pilot study to test the feasibility of histological characterisation of asthma-COPD overlap.

Papakonstantinou E, Savic S, Siebeneichler A, Strobel W, Jones PW, Tamm M, Stolz D.

Eur Respir J. 2019 Jun 5;53(6). pii: 1801941. doi: 10.1183/13993003.01941-2018. Print 2019 Jun. No abstract available.

PMID:
30880282
16.

Long acting β2-agonist's activation of cyclic AMP cannot halt ongoing mitogenic stimulation in airway smooth muscle cells.

Qi Y, Fang L, Stolz D, Tamm M, Roth M.

Pulm Pharmacol Ther. 2019 Jun;56:20-28. doi: 10.1016/j.pupt.2019.03.005. Epub 2019 Mar 12.

PMID:
30876906
17.

IgE Downregulates PTEN through MicroRNA-21-5p and Stimulates Airway Smooth Muscle Cell Remodeling.

Fang L, Wang X, Sun Q, Papakonstantinou E, S'ng C, Tamm M, Stolz D, Roth M.

Int J Mol Sci. 2019 Feb 18;20(4). pii: E875. doi: 10.3390/ijms20040875.

18.

Pelargonium sidoides radix extract EPs 7630 reduces rhinovirus infection through modulation of viral binding proteins on human bronchial epithelial cells.

Roth M, Fang L, Stolz D, Tamm M.

PLoS One. 2019 Feb 1;14(2):e0210702. doi: 10.1371/journal.pone.0210702. eCollection 2019.

19.

Serum levels of hyaluronic acid are associated with COPD severity and predict survival.

Papakonstantinou E, Bonovolias I, Roth M, Tamm M, Schumann D, Baty F, Louis R, Milenkovic B, Boersma W, Stieltjes B, Kostikas K, Blasi F, Aerts JG, Rohde GGU, Lacoma A, Torres A, Welte T, Stolz D.

Eur Respir J. 2019 Mar 7;53(3). pii: 1801183. doi: 10.1183/13993003.01183-2018. Print 2019 Mar.

PMID:
30705130
20.

Adrenomedullin mediates pro-angiogenic and pro-inflammatory cytokines in asthma and COPD.

Mandal J, Roth M, Papakonstantinou E, Fang L, Savic S, Tamm M, Stolz D.

Pulm Pharmacol Ther. 2019 Jun;56:8-14. doi: 10.1016/j.pupt.2019.01.006. Epub 2019 Jan 25.

PMID:
30690080

Supplemental Content

Loading ...
Support Center